Skip to main content
Clinical Trials/IRCT20091018002604N5
IRCT20091018002604N5
Completed
Phase 3

Influence of growth hormone supplementation on pregnancy outcome of patients undergoing frozen thawed embryo transfer(FET)

Vice chancellor for research,Shahid Sadoughi University of Medical Science,Yazd,Iran0 sites100 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice chancellor for research,Shahid Sadoughi University of Medical Science,Yazd,Iran
Enrollment
100
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice chancellor for research,Shahid Sadoughi University of Medical Science,Yazd,Iran

Eligibility Criteria

Inclusion Criteria

  • 20\-40 years old infertile patient candidate for frozen thawed embryo transfer

Exclusion Criteria

  • uterus malformation\-sever endometriosis and adenomyosis\-uterus adhesion\-recurrent implantation failure

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Investigating the results of adding growth hormone to the ovulation stimulation regimen in microinjection and In Vitro Fertilization in patients with low ovarian reserve
IRCT20130603013566N13Vice chancellor for Research,Tabriz University Of Medical Sciences96
Active, not recruiting
Phase 1
ong-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner SyndromeTurner SyndromeMedDRA version: 19.0Level: LLTClassification code 10063020Term: Parsonage-Turner syndromeSystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2016-001502-42-Outside-EU/EEAEli Lilly and Company Limited88
Completed
Phase 2
Influence of exogenous growth hormone administration on circulating levels of Klotho in healthy and chronic kidney disease subjects
NL-OMON40366Vrije Universiteit Medisch Centrum20
Active, not recruiting
Not Applicable
Influence of growth hormone administered subcutaneously on circulating Klotho levels in healthy subjects and subjects with renal failure.Cardiovascular disease in chronic kidney diseaseTherapeutic area: Body processes [G] - Metabolic Phenomena [G03]
EUCTR2013-003354-24-NLVrij Universiteit Medical Center
Completed
Not Applicable
Influence of exogenous growth hormone administration on circulating levels of Klotho in paediatric patients with isolated growth hormone deficiency.Klotho levels in isolated growth hormone deficiency10021112
NL-OMON44245Vrije Universiteit Medisch Centrum20